GrantRover ↗

← Tüm konular

Konu

Kanser araştırmaları: fon fırsatları

Önlemeden erken teşhise, tedaviden yaşam kalitesine kanser araştırmaları için çağrılar.

50 güncel çağrı · ABD 42 · Avrupa Birliği 8 · 5 çağrı 30 gün içinde kapanıyor

Bu alan için ipuçları

Güncel çağrılar, en yakın son tarih önce

National Institutes of Health ABD

Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21…

PAR-25-096

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) along with other participating Institutes encourages submission of applications pro…

Defense Health Agency Contracting Activity - DHACA ABD

DoW Breast Cancer, Breakthrough Award Levels 1 and 2

HT942526BCRPBTA122

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Breakthrough Award mechanism supports promising research with high potential to lead to or make…

Defense Health Agency Contracting Activity - DHACA ABD

DoW Breast Cancer, Clinical Research Extension Award

HT942526BCRPCREA2

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Clinical Research Extension Award supports research that extends the data collection, follow-up…

Defense Health Agency Contracting Activity - DHACA ABD

DoW Rare Cancers Idea Development Award

HT942526RCRPIDA

Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Idea Development Award (IDA) promotes ideas that are ready for further development and have the …

Defense Health Agency Contracting Activity - DHACA ABD

DoW Rare Cancers Resource and Community Development Award

HT942526RCRPRCDA

Summary: The fiscal year 2026 (FY26) Rare Cancers Research Program (RCRP) Resource and Community Development Award (RCDA) supports the development of research resources a…

National Institutes of Health ABD

NCI Research Specialist Award for Core and Laboratory-based Scientists (R50 Clinical Trial Not Allowed)

PAR-27-088

This notice of funding opportunity (NOFO) will invite applications for the Research Specialist Award (R50), which provides salary support for exceptional, non-tenure trac…

National Institutes of Health ABD

Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)

PAR-25-079

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate translation of scientific discoveries and engineering developm…

National Institutes of Health ABD

Interventions to expand cancer screening and preventive services to ADVANCE… (R01, Clinical Trial Required)

PAR-25-098

The Office of Disease Prevention (ODP) and participating National Institutes of Health (NIH) Institutes, Centers, and Offices (ICs) are issuing this R01 to solicit applic…

National Institutes of Health ABD

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R01 Clinical Trial Optional)

PAR-25-069

The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (inc…

National Institutes of Health ABD

Mechanisms that Impact Cancer Risk with Use of Incretin Mimetics (R21 Clinical Trial Not Allowed)

PAR-25-070

The goal of the proposed funding announcement is twofold, to promote preclinical and patient based studies examining the mechanism(s) through which incretin mimetics (inc…

National Institutes of Health ABD

National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials… (R01 Clinical Trial Required)

PAR-25-081

Through this Notice of Funding Opportunity, the National Cancer Institute (NCI) seeks research projects that implement early phase (Phase 0, I, and II) investigator-initi…

National Institutes of Health ABD

Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional)

PAR-25-221

This Notice of Funding Opportunity (NOFO) aims to support research on interdisciplinary population approaches to increasing awareness of the relationship between alcohol …

National Institutes of Health ABD

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

PAR-26-149

This Notice of Funding Opportunity (NOFO) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-Designated Cancer Centers. CCSGs support three …

National Institutes of Health ABD

Innovative Research to Improve Native Hawaiian and Pacific Islander (NHPI) Health Outcomes (R34

RFA-MD-27-004

The National Institute on Minority Health and Health Disparities (NIMHD), intends to publish a Notice of Funding Opportunity (NOFO) for planning grants to support prepara…

National Institutes of Health ABD

Partnership with Common Fund Data Ecosystem Resources

RFA-RM-28-009

The NIH Office of Strategic Coordination (Common Fund) has generated many valuable and widely available datasets. The Common Fund Data Ecosystem is helping to ensure that…

National Institutes of Health ABD

Advanced Development and Validation of Emerging Technologies for Basic and… (R33 Clinical Trial Not Allowed)

RFA-CA-28-002

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing exploratory research projects focused on furt…

National Institutes of Health ABD

Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)

RFA-CA-28-001

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing to develop innovative technologies for cancer…

Horizon Europe Avrupa Birliği

Clinical research by Comprehensive Cancer Infrastructures for the benefit of patients with common cancers

HORIZON-MISS-2027-02-CANCER-02

Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes: • Patients affl…

Horizon Europe Avrupa Birliği

Improving equitable health outcomes and added value for and with cancer patients through health-economics…

HORIZON-MISS-2027-02-CANCER-04

Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes: • People at ris…

Horizon Europe Avrupa Birliği

Leveraging functional genomics to reveal novel targets for cancer treatment

HORIZON-MISS-2027-02-CANCER-01

Proposals under this topic should aim to deliver results that are directed and tailored towards and contribute to all of the following expected outcomes: • Researchers an…

Horizon Europe Avrupa Birliği

Phase 1 including first-in-human clinical trials to test biomarker-guided medicines or multi-modal treatment…

HORIZON-MISS-2027-02-CANCER-03

Proposals under this topic should aim to deliver results that are directed and tailored towards, and contribute to all of the following expected outcomes: • Patients with…

Horizon Europe Avrupa Birliği

Pre-commercial procurement of affordable solutions for healthcare systems in the areas of cancer technologies…

HORIZON-MISS-2027-02-CANCER-05

This action supports the follow-up to the July 2023 Communication on EU Missions assessment [1] . Proposals under this topic should aim to deliver results that are direct…

Horizon Europe Avrupa Birliği

Support a Young Cancer Survivor Quality of Life (QoL) research programme by cancer charities and funding agencies

HORIZON-MISS-2027-02-CANCER-06

This action supports the follow-up to the July 2023 Communication on EU Missions assessment [1] . The successful proposal under this topic should aim to deliver results t…

National Institutes of Health ABD

Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)

PAR-25-104

The purpose of this FOA is to facilitate well planned clinical trials across the cancer prevention and control spectrum aimed at improving prevention/ interception, cance…

National Institutes of Health ABD

Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)

PAR-25-336

Through this Notice of Funding Opportunity (NOFO), entitled "Toward Translation of Nanotechnology Cancer Interventions" (TTNCI), the National Cancer Institute (NCI) encou…

National Institutes of Health ABD

Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)

PAR-25-244

This Notice of Funding Opportunity (NOFO) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/geneti…

National Institutes of Health ABD

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01

PAR-25-337

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate efforts to translate scientific discoveries and engineering de…

National Institutes of Health ABD

Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01

PAR-25-338

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to stimulate efforts to translate scientific discoveries and engineering de…

National Institutes of Health ABD

Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)

PAR-25-243

This Notice of Funding Opportunity (NOFO) encourages grant applications from investigators interested in conducting basic, mechanistic research into the biological/geneti…

National Institutes of Health ABD

Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and… (R01 Clinical Trial Optional)

PAR-25-145

The purpose of this Funding Opportunity Announcement (FOA) is to support collaborative research projects designed to address adverse sequelae of cancer therapies that per…

National Institutes of Health ABD

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)

PAR-25-346

Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to encourage submissions of exploratory/developmental …

National Institutes of Health ABD

Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)

PAR-25-321

Through this engineering-oriented Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) intends to encourage submissions of exploratory/developmental …

National Institutes of Health ABD

Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional)

PAR-25-175

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) seeks research project (R01) grant applications describing projects that integrate …

National Institutes of Health ABD

Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)

PAR-25-299

This initiative will support multi-level and/or multi-domain intervention research to reduce disparities in liver diseases and liver cancer among populations who experien…

National Institutes of Health ABD

Mechanisms that Impact Cancer Risk after Bariatric Surgery (R21 Clinical Trial Not Allowed)

PAR-25-044

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for support of investigator-initiated studies addressing mecha…

National Institutes of Health ABD

Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed)

PAR-24-311

The purpose of this Notice of Funding Opportunity (NOFO) is to invite research grant applications (R01) for the development and use of current and emerging molecular imag…

National Institutes of Health ABD

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

PA-25-253

This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of ca…

National Institutes of Health ABD

Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)

PAR-25-324

The National Cancer Institute (NCI) Method to Extend Research in Time (MERIT) (R37) Award provides extended grant support to Early Stage Investigators (ESIs). By providin…

National Institutes of Health ABD

Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)

PAR-25-444

This Notice of Funding Opportunity (NOFO) invites applications for P30 Cancer Center Support Grants (CCSGs) to support NCI-Designated Cancer Centers. CCSGs support three …

National Institutes of Health ABD

Paul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Not Allowed)

PAR-27-025

The goal of the Paul Calabresi Career Development Award for Clinical Oncology (PCACO) is to increase the number of clinician-scientists trained in clinical and translatio…

National Institutes of Health ABD

Research Opportunities in Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)

PAR-27-073

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) encourages grant applications to support research in cancer epidemiology cohort stu…

National Institutes of Health ABD

Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years… (P50 Clinical Trial Required)

PAR-28-022

Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) invites applications for P50 Research Center Grants for Specialized Programs of Res…

National Institutes of Health ABD

Early-Onset Cancers: Investigating Etiology, Mechanisms, and Early Detection Strategies (RP1 Clinical Trials Optional)

PAR-28-014

This Notice of Funding Opportunity (NOFO) invites applications that investigate the etiology of sporadic non-hereditary early-onset cancers (EOCs: ages 18 to 49 years) an…

Konu sayfaları çağrıları resmi başlık, açıklama ve anahtar kelimelerindeki terimlere göre eşleştirir. Eşleşme uygunluk kararı değildir.